$310.31
0[0.00%]
At close: Apr 22
$310.31
0[0.00%]
PreMarket: 4:20PM EDT
HCA Healthcare
(NYSE:HCA)HCA Healthcare Stock (NYSE:HCA), Analyst Ratings, Price Targets, Predictions
HCA Healthcare Inc has a consensus price target of $290.43, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, Cantor Fitzgerald, and Wells Fargo on April 12, 2024, April 10, 2024, and March 28, 2024. With an average price target of $336.33 between Deutsche Bank, Cantor Fitzgerald, and Wells Fargo, there's an implied 8.39% upside for HCA Healthcare Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Deutsche Bank
Cantor Fitzgerald
Wells Fargo
Barclays
Raymond James
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for HCA Healthcare
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 15.69% | Deutsche Bank | Pito Chickering | $330 → $359 | Maintains | Buy | Get Alert |
| 04/10/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 7.96% | Cantor Fitzgerald | Sarah James | → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 1.51% | Wells Fargo | Stephen Baxter | $303 → $315 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 14.72% | Barclays | Andrew Mok | → $356 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 7.96% | Cantor Fitzgerald | Sarah James | → $335 | Reiterates | Overweight → Overweight | Get Alert |
| 01/31/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 6.35% | Raymond James | John Ransom | $300 → $330 | Maintains | Outperform | Get Alert |
| 01/31/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 3.77% | RBC Capital | Ben Hendrix | $308 → $322 | Maintains | Outperform | Get Alert |
| 01/31/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 11.18% | Truist Securities | David Macdonald | $320 → $345 | Maintains | Buy | Get Alert |
| 01/24/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | -3.32% | Raymond James | John Ransom | $280 → $300 | Maintains | Outperform | Get Alert |
| 01/19/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 1.51% | Cantor Fitzgerald | Sarah James | → $315 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | 1.51% | Oppenheimer | Michael Wiederhorn | → $315 | Reiterates | Outperform → Outperform | Get Alert |
| 01/04/2024 | HCA | Buy Now | HCA Healthcare | $310.31 | -3% | Bernstein | Lance Wilkes | → $301 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2023 | HCA | Buy Now | HCA Healthcare | $310.31 | — | Goldman Sachs | Jamie Perse | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2023 | HCA | Buy Now | HCA Healthcare | $310.31 | -14.6% | JP Morgan | Samik Chatterjee | $313 → $265 | Maintains | Neutral | Get Alert |
| 11/10/2023 | HCA | Buy Now | HCA Healthcare | $310.31 | -9.77% | Stephens & Co. | Scott Fidel | → $280 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2023 | HCA | Buy Now | HCA Healthcare | $310.31 | -9.45% | Goldman Sachs | Jamie Perse | $329 → $281 | Maintains | Buy | Get Alert |
| 10/26/2023 | HCA | Buy Now | HCA Healthcare | $310.31 | -18.15% | Wells Fargo | Stephen Baxter | $267 → $254 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $310.31 | -3.32% | Truist Securities | David Macdonald | $340 → $300 | Maintains | Buy | Get Alert |
| 10/25/2023 | HCA | Buy Now | HCA Healthcare | $310.31 | -11.38% | Mizuho | Ann Hynes | $325 → $275 | Maintains | Buy | Get Alert |
FAQ
What is the target price for HCA Healthcare (HCA)?
The latest price target for HCA Healthcare (NYSE: HCA) was reported by Deutsche Bank on April 12, 2024. The analyst firm set a price target for $359.00 expecting HCA to rise to within 12 months (a possible 15.69% upside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HCA Healthcare (HCA)?
The latest analyst rating for HCA Healthcare (NYSE: HCA) was provided by Deutsche Bank, and HCA Healthcare maintained their buy rating.
When was the last upgrade for HCA Healthcare (HCA)?
The last upgrade for HCA Healthcare Inc happened on May 27, 2022 when Bernstein raised their price target to $271. Bernstein previously had a market perform for HCA Healthcare Inc.
When was the last downgrade for HCA Healthcare (HCA)?
The last downgrade for HCA Healthcare Inc happened on January 4, 2024 when Bernstein changed their price target from N/A to $301 for HCA Healthcare Inc.
When is the next analyst rating going to be posted or updated for HCA Healthcare (HCA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCA Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCA Healthcare was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating HCA Healthcare (HCA) correct?
While ratings are subjective and will change, the latest HCA Healthcare (HCA) rating was a maintained with a price target of $330.00 to $359.00. The current price HCA Healthcare (HCA) is trading at is $310.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.